drugset / Trial / NCT00657761

Metabolic Effects of Enfuvirtide in Healthy Volunteers

NCT00657761

RandomizedCrossoverQuadruple-blind

Summary

The metabolic effects of T-20 are not completely known, since the drug is used in combination with other antiretroviral agents. A short-term study in healthy volunteers, with a double-blind crossover design vs. placebo will illustrate if there may be some direct metabolic effects without the influence of HIV infection and the concurrent use of other drugs.

Timeline

Start
2005-09
Primary completion
2006-03
Completion
2006-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Enfuvirtide Peptide 90 mg Subcutaneous